Search

everythinglearnresearchcommunity

for

Search:↓

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Suppressing certain hormones might help prevent prostate cancer.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Different body parts have varying levels of certain hair follicle markers.

Women who had cancer treatment feel both positive and negative about their bodies.

Breast cancer may be detectable through changes in scalp hair lipids.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

People with alopecia areata may have a higher risk of blood clots.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

PLD is an effective and safer alternative for treating breast cancer.

Obese women with PCOS are more likely to have fatty liver disease.

Telogen is an active phase with important biological processes, not a resting phase.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Apoptosis may contribute to hair loss in androgenetic alopecia.